Context Therapeutics Shares Surge On Encouraging Data From Onapristone In Early Breast Cancer

By: via Benzinga
Context Therapeutics Inc(NASDAQ: CNTX) posteddata from the window-of-opportunity trialof onapristone extended-release ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.